Mylan NV (NASDAQ:MYL)

Monday’s trading has closed, but MYL is being traded in the after-hours session. After-Hours quote »
73.05
Delayed Data
As of 4:00pm ET
 -0.84 / -1.14%
Today’s Change
44.80
Today|||52-Week Range
76.69
+29.59%
Year-to-Date
Report Sees 'Cognitive Dissonance' In Mylan's Internal Price Target
5:41pm / Benzinga
Perrigo Rejects Mylan's Offer Again, Cites Undervaluation - Analyst Blog
Apr 27 / Zacks.com
Can Mylan (MYL) Specialty Segment Secure Earnings Beat? - Analyst Blog
4:36pm / Zacks.com
Mylan (MYL) Stock Declines Today After Board Unanimously Rejects Teva Offer
Apr 27 / TheStreet.com
3 Best Performing Stocks in April - Analyst Blog
10:35am / Zacks.com
No end in sight to wave of pharma dealmaking
Apr 26 / FT.com
Groupon, Alibaba, Tesla & Others On Deck: Earnings Season Rolls On
May 03 / Benzinga
Perrigo rejects formal Mylan takeover offer
Apr 24 / FT.com
UK election and US jobs report to dominate a packed week
May 03 / FT.com
Mylan readies its poison pill defences
Apr 22 / FT.com
What's It Worth? Merger Mania Means Generic-Drug Makers Disagree
May 03 / MotleyFool.com
Teva Proposes to Buy Mylan, Sends Shares Up - Analyst Blog
Apr 22 / Zacks.com
Teva Pharmaceutical Industries Ltd Posts Solid Quarter, Stays Mum on Mylan
Apr 30 / MotleyFool.com
Abbott Labs (ABT) Beats on Q1 Earnings, View Reiterated - Analyst Blog
Apr 22 / Zacks.com
Teva Pharmaceutical Industries Ltd. Posts Strong First-Quarter Earnings: Is the Stock...
Apr 30 / MotleyFool.com
Surprising stocks push Nasdaq closer to record
Apr 22 / CNNMoney.com
Teva Beats on Q1 Earnings by Wide Margin, Ups View - Analyst Blog
Apr 30 / Zacks.com
Stock Market News for April 22, 2015 - Market News
Apr 22 / Zacks.com
Benzinga's M&A Chatter for Wednesday April 29, 2015
Apr 29 / Benzinga
Perrigo Beats on Q3 Earnings, Gives View, Rejects Mylan Bid - Analyst Blog
Apr 22 / Zacks.com
Market Wrap: Fed Keeps Rate Hike in Sights; Q1 GDP Growth Lags Views; The Teva/Perrig...
Apr 29 / Investing Channel
Roche boosted by US drugs sales
Apr 22 / FT.com
Mylan Raises Its Offer for Generics Counterpart Perrigo
Apr 29 / TheStreet.com
Japan shines in solid session for Asia bourses
Apr 21 / FT.com
3 Drugs Stocks Driving The Industry Higher
Apr 29 / TheStreet.com
Why Mylan NV Is Suddenly in the Driver's Seat
Apr 21 / MotleyFool.com
Perrigo rebuffs sweetened $35.6bn offer from Mylan
Apr 29 / FT.com
Teva seeks cushion against loss of patent protection
Apr 21 / FT.com
Mylan (MYL) Stock Rises After Increasing Perrigo Offer a Second Time
Apr 29 / TheStreet.com
Teva/Mylan: Brand management
Apr 21 / FT.com
Will Teva's (TEVA) Earnings Streak Continue in Q1? - Analyst Blog
Apr 28 / Zacks.com
Harley-Davidson brakes on lower shipment forecasts
Apr 21 / FT.com
Stock Market News for April 28, 2015 - Market News
Apr 28 / Zacks.com
Israel's Teva offers $40.1bn for US drugmaker Mylan
Apr 21 / FT.com
Fast Money Picks For April 28
Apr 28 / Benzinga
Mylan dismisses takeover interest from Teva Pharmaceuticals
Apr 17 / FT.com
Benzinga's M&A Chatter for Monday April 27, 2015
Apr 28 / Benzinga
Week in Review, April 11
Apr 10 / FT.com
Market Wrap: Apple Does it Again in Q2; Mylan Rejects Teva Bid; Applied Materials, To...
Apr 27 / Investing Channel
Mylan makes $28.9bn offer for Perrigo
Apr 08 / FT.com
Mylan Rejects Teva's Unsolicited Bid, While Teva Reiterates Its Original Offer
Apr 27 / TheStreet.com
US energy fades despite European M&A
Apr 08 / FT.com
Mylan rounds on Teva as it rejects $40bn bid
Apr 27 / FT.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account